8,816
Views
29
CrossRef citations to date
0
Altmetric
Review

Measles virus

A pathogen, vaccine, and a vector

Pages 21-26 | Received 04 Aug 2014, Accepted 04 Aug 2014, Published online: 01 Nov 2014

References

  • Krugman S, Katz SL, Gershon AA, Wilfert C. Measles. In: Infectious diseases of Children 1985; 8th edn. Mosby, St Louis, 152-166.
  • OtriAM, SinghAD, DuaHS. Cover illustration. Abu Bakr Razi. [BMJ Group]Br J Ophthalmol2008; 92:1324; PMID: 18815419
  • ClementsCJ, CuttsFT. The epidemiology of measles: thirty years of vaccination. Curr Top Microbiol Immunol1995; 191:13 - 33; http://dx.doi.org/10.1007/978-3-642-78621-1_2; PMID: 7789156
  • Chen SSP, Fennelly G, Burnett M, Domachowske J, Dyne PL, Elston DM, et al. “Measles” 2014; In Steele, RW. Medscape Reference. WebMD. Retrieved 23 March 2014
  • Risk of infection East and Southwest Asia (Report). Occucare International. May 16, 2012; p. 6
  • WildTF, BucklandR. Functional aspects of envelope-associated measles virus proteins. Curr Top Microbiol Immunol1995; 191:51 - 64; http://dx.doi.org/10.1007/978-3-642-78621-1_4; PMID: 7789162
  • YanagiY, TakedaM, OhnoS, HashiguchiT. Measles virus receptors. Curr Top Microbiol Immunol2009; 329:13 - 30; http://dx.doi.org/10.1007/978-3-540-70523-9_2; PMID: 19198560
  • KemperC, AtkinsonJP. Measles virus and CD46. Curr Top Microbiol Immunol2009; 329:31 - 57; http://dx.doi.org/10.1007/978-3-540-70523-9_3; PMID: 19198561
  • SakaguchiM, YoshikawaY, YamanouchiK, SataT, NagashimaK, TakedaK. Growth of measles virus in epithelial and lymphoid tissues of cynomolgus monkeys. Microbiol Immunol1986; 30:1067 - 73; http://dx.doi.org/10.1111/j.1348-0421.1986.tb03036.x; PMID: 3796316
  • YamanouchiK, ChinoF, KobuneF, KodamaH, TsuruharaT. Growth of measles virus in the lymphoid tissues of monkeys. J Infect Dis1973; 128:795 - 9; http://dx.doi.org/10.1093/infdis/128.6.795; PMID: 4203079
  • LiebertUG, FinkeD. Measles virus infections in rodents. Curr Top Microbiol Immunol1995; 191:149 - 66; http://dx.doi.org/10.1007/978-3-642-78621-1_10; PMID: 7789158
  • BaxbyD. Classic Paper: Henry Koplik. The diagnosis of the invasion of measles from a study of the exanthema as it appears on the buccal membrane. Rev Med Virol1997; 7:71 - 4; http://dx.doi.org/10.1002/(SICI)1099-1654(199707)7:2<71::AID-RMV185>3.0.CO;2-S; PMID: 10398471
  • KandaE, YamaguchiK, HanaokaM, MatsuiH, SagoH, KuboT. Low titers of measles antibodies in Japanese pregnant women: a single-center study. J Obstet Gynaecol Res2013; 39:500 - 3; http://dx.doi.org/10.1111/j.1447-0756.2012.01997.x; PMID: 22925573
  • BreitfeldV, HashidaY, ShermanFE, OdagiriK, YunisEJ. Fatal measles infection in children with leukemia. Lab Invest1973; 28:279 - 91; PMID: 4348408
  • GowdaVK, SukanyaV, Shivananda. Acquired immunodeficiency syndrome with subacute sclerosing panencephalitis. Pediatr Neurol2012; 47:379 - 81; http://dx.doi.org/10.1016/j.pediatrneurol.2012.06.020; PMID: 23044024
  • AnlarB. Subacute sclerosing panencephalitis and chronic viral encephalitis. Handb Clin Neurol2013; 112:1183 - 9; http://dx.doi.org/10.1016/B978-0-444-52910-7.00039-8; PMID: 23622327
  • Ter Meulen V, Stephenson JR, Kreth HW. Subacute sclerosing panencephalitis. In Fraenkel-Conrat H, Wagner RR (eds) Compr Virol 1983; 18: 105-159.
  • KatzM. Clinical spectrum of measles. Curr Top Microbiol Immunol1995; 191:1 - 12; http://dx.doi.org/10.1007/978-3-642-78621-1_1; PMID: 7789153
  • ter MeulenV, MüllerD, KäckellY, KatzM, MeyermannR. Isolation of infectious measles virus in measles encephalitis. Lancet1972; 2:1172 - 5; http://dx.doi.org/10.1016/S0140-6736(72)92595-0; PMID: 4117594
  • EhrengruberMU, EhlerE, BilleterMA, NaimHY. Measles virus spreads in rat hippocampal neurons by cell-to-cell contact and in a polarized fashion. J Virol2002; 76:5720 - 8; http://dx.doi.org/10.1128/JVI.76.11.5720-5728.2002; PMID: 11992000
  • Measles, World Health Organization Fact sheet N°286. Retrieved June 28, 2012; Updated February 2014
  • Millennium Development Goals. United Nations. Retrieved 18 March 2013
  • PolonskyJA, RonsseA, CigleneckiI, RullM, PortenK. High levels of mortality, malnutrition, and measles, among recently-displaced Somali refugees in Dagahaley camp, Dadaab refugee camp complex, Kenya, 2011. Confl Health2013; 7:1; http://dx.doi.org/10.1186/1752-1505-7-1; PMID: 23339463
  • DiazT, NuñezJC, RullanJV, MarkowitzLE, BarkerND, HoranJ. Risk factors associated with severe measles in Puerto Rico. Pediatr Infect Dis J1992; 11:836 - 40; http://dx.doi.org/10.1097/00006454-199210000-00006; PMID: 1408482
  • EndersJF, PeeblesTC. Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med1954; 86:277 - 86; http://dx.doi.org/10.3181/00379727-86-21073; PMID: 13177653
  • EndersJF. Measles virus. Historical review, isolation, and behavior in various systems. Am J Dis Child1962; 103:282 - 7; http://dx.doi.org/10.1001/archpedi.1962.02080020294021; PMID: 13890170
  • KatzSL, EndersJF, HollowayA. The development and evaluation of an attenuated measles virus vaccine. Am J Public Health Nations Health1962; 52:25 - 10; http://dx.doi.org/10.2105/AJPH.52.Suppl_2.5; PMID: 14454407
  • KrugmanS, GilesJP, FriedmanH, StoneS. Studies on immunity to measles. J Pediatr1965; 66:471 - 88; http://dx.doi.org/10.1016/S0022-3476(65)80112-3; PMID: 14264306
  • KarzonDT, RushD, WinkelsteinWJr.. Immunization with inactivated measles virus vaccine: effect of booster dose and response to natural challenge. Pediatrics1965; 36:40 - 50; PMID: 14313365
  • Centers for Disease Control Recommendations of the public health service advisory committee on immunization and practice. Measles vaccines. Morb Mortal Wkly Rep1967; 16:269 - 71
  • RimaBK, EarleJA, BaczkoK, RotaPA, BelliniWJ. Measles virus strain variations. Curr Top Microbiol Immunol1995; 191:65 - 83; http://dx.doi.org/10.1007/978-3-642-78621-1_5; PMID: 7789163
  • ZunigaA, LinigerM, MorinTN, MartyRR, WiegandM, IlterO, WeibelS, BilleterMA, KnuchelMC, NaimHY. Sequence and immunogenicity of a clinically approved novel measles virus vaccine vector. Hum Vaccin Immunother2013; 9:607 - 13; http://dx.doi.org/10.4161/hv.23242; PMID: 23324616
  • GriffinDE, PanCH. Measles: old vaccines, new vaccines. Curr Top Microbiol Immunol2009; 330:191 - 212; http://dx.doi.org/10.1007/978-3-540-70617-5_10; PMID: 19203111
  • GalindoBM, ConcepciónD, GalindoMA, PérezA, SaizJ. Vaccine-related adverse events in Cuban children, 1999-2008. MEDICC Rev2012; 14:38 - 43; PMID: 22334111
  • HelfandRF, WitteD, FowlkesA, GarciaP, YangC, FudzulaniR, WallsL, BaeS, StrebelP, BroadheadR, et al. Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi. J Infect Dis2008; 198:1457 - 65; http://dx.doi.org/10.1086/592756; PMID: 18828743
  • OłdakowskaA, MarczyńskaM. [Measles vaccination in HIV infected children]. Med Wieku Rozwoj2008; 12:675 - 80; PMID: 19418943
  • KupferschmidtK. Public health. Europe’s embarrassing problem. Science2012; 336:406 - 7; http://dx.doi.org/10.1126/science.336.6080.406; PMID: 22539695
  • HillemanMR. Past, present, and future of measles, mumps, and rubella virus vaccines. Pediatrics1992; 90:149 - 53; PMID: 1603640
  • Measles Surveillance Data after WHO, last updated 2014-3-6WHO: Global summary on measles, 2006 http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/active/measles_monthlydata/en/
  • KhanumS, UddinN, GarelickH, MannG, TomkinsA. Comparison of Edmonston-Zagreb and Schwarz strains of measles vaccine given by aerosol or subcutaneous injection. Lancet1987; 1:150 - 3; http://dx.doi.org/10.1016/S0140-6736(87)91978-7; PMID: 2879981
  • DilrajA, SukhooR, CuttsFT, BennettJV. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination. Vaccine2007; 25:4170 - 4; http://dx.doi.org/10.1016/j.vaccine.2007.03.003; PMID: 17408818
  • BennettJV, Fernandez de CastroJ, Valdespino-GomezJL, Garcia-GarciaMdeL, Islas-RomeroR, Echaniz-AvilesG, Jimenez-CoronaA, Sepulveda-AmorJ. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren. Bull World Health Organ2002; 80:806 - 12; PMID: 12471401
  • DilrajA, CuttsFT, de CastroJF, WheelerJG, BrownD, RothC, CoovadiaHM, BennettJV. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial. Lancet2000; 355:798 - 803; http://dx.doi.org/10.1016/S0140-6736(99)95140-1; PMID: 10711928
  • MillerC. Live measles vaccine: a 21 year follow up. Br Med J (Clin Res Ed)1987; 295:22 - 4; http://dx.doi.org/10.1136/bmj.295.6589.22; PMID: 3113599
  • XiangJZ, ChenZH. Measles vaccine in the People’s Republic of China. Rev Infect Dis1983; 5:506 - 10; http://dx.doi.org/10.1093/clinids/5.3.506; PMID: 6879006
  • ZhiangY, SuW. Introduction to the control of measles by vaccination in the People’s Republic of China. Rev Infect Dis1983; 5:568 - 73; http://dx.doi.org/10.1093/clinids/5.3.568; PMID: 6879016
  • ReyesMA, de BorreroMF, RoaJ, BergonzoliG, SaraviaNG. Measles vaccine failure after documented seroconversion. Pediatr Infect Dis J1987; 6:848 - 51; http://dx.doi.org/10.1097/00006454-198709000-00012; PMID: 3670952
  • RadeckeF, SpielhoferP, SchneiderH, KaelinK, HuberM, DötschC, ChristiansenG, BilleterMA. Rescue of measles viruses from cloned DNA. EMBO J1995; 14:5773 - 84; PMID: 8846771
  • ValsamakisA, SchneiderH, AuwaerterPG, KaneshimaH, BilleterMA, GriffinDE. Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J Virol1998; 72:7754 - 61; PMID: 9733811
  • TakedaM, OhnoS, SekiF, NakatsuY, TaharaM, YanagiY. Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicity. J Virol2005; 79:14346 - 54; http://dx.doi.org/10.1128/JVI.79.22.14346-14354.2005; PMID: 16254369
  • DevauxP, HodgeG, McChesneyMB, CattaneoR. Attenuation of V- or C-defective measles viruses: infection control by the inflammatory and interferon responses of rhesus monkeys. J Virol2008; 82:5359 - 67; http://dx.doi.org/10.1128/JVI.00169-08; PMID: 18385234
  • NaimHY, EhlerE, BilleterMA. Measles virus matrix protein specifies apical virus release and glycoprotein sorting in epithelial cells. EMBO J2000; 19:3576 - 85; http://dx.doi.org/10.1093/emboj/19.14.3576; PMID: 10899112
  • PattersonJB, CornuTI, RedwineJ, DalesS, LewickiH, HolzA, ThomasD, BilleterMA, OldstoneMB. Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease. Virology2001; 291:215 - 25; http://dx.doi.org/10.1006/viro.2001.1182; PMID: 11878891
  • DuprexWP, McQuaidS, HangartnerL, BilleterMA, RimaBK. Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J Virol1999; 73:9568 - 75; PMID: 10516065
  • ZunigaA, WangZ, LinigerM, HangartnerL, CaballeroM, PavlovicJ, WildP, ViretJF, GlueckR, BilleterMA, et al. Attenuated measles virus as a vaccine vector. Vaccine2007; 25:2974 - 83; http://dx.doi.org/10.1016/j.vaccine.2007.01.064; PMID: 17303293
  • DuprexWP, CollinsFM, RimaBK. Modulating the function of the measles virus RNA-dependent RNA polymerase by insertion of green fluorescent protein into the open reading frame. J Virol2002; 76:7322 - 8; http://dx.doi.org/10.1128/JVI.76.14.7322-7328.2002; PMID: 12072530
  • EhrengruberMU, HennouS, BüelerH, NaimHY, DéglonN, LundstromK. Gene transfer into neurons from hippocampal slices: comparison of recombinant Semliki Forest Virus, adenovirus, adeno-associated virus, lentivirus, and measles virus. Mol Cell Neurosci2001; 17:855 - 71; http://dx.doi.org/10.1006/mcne.2001.0982; PMID: 11358483
  • PengKW, FrenzkeM, MyersR, SoeffkerD, HarveyM, GreinerS, GalanisE, CattaneoR, FederspielMJ, RussellSJ. Biodistribution of oncolytic measles virus after intraperitoneal administration into Ifnar-CD46Ge transgenic mice. Hum Gene Ther2003; 14:1565 - 77; http://dx.doi.org/10.1089/104303403322495070; PMID: 14577918
  • WangZ, HangartnerL, CornuTI, MartinLR, ZunigaA, BilleterMA, NaimHY. Recombinant measles viruses expressing heterologous antigens of mumps and simian immunodeficiency viruses. Vaccine2001; 19:2329 - 36; http://dx.doi.org/10.1016/S0264-410X(00)00523-5; PMID: 11257357
  • TangyF, NaimHY. Live attenuated measles vaccine as a potential multivalent pediatric vaccination vector. Viral Immunol2005; 18:317 - 26; http://dx.doi.org/10.1089/vim.2005.18.317; PMID: 16035943
  • LinigerM, ZunigaA, MorinTN, CombardiereB, MartyR, WiegandM, IlterO, KnuchelM, NaimHY. Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses. Vaccine2009; 27:3299 - 305; http://dx.doi.org/10.1016/j.vaccine.2009.01.057; PMID: 19200842
  • LinigerM, ZunigaA, NaimHY. Use of viral vectors for the development of vaccines. Expert Rev Vaccines2007; 6:255 - 66; http://dx.doi.org/10.1586/14760584.6.2.255; PMID: 17408374
  • CombredetC, LabrousseV, MolletL, LorinC, DelebecqueF, HurtrelB, McClureH, FeinbergMB, BrahicM, TangyF. A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice. J Virol2003; 77:11546 - 54; http://dx.doi.org/10.1128/JVI.77.21.11546-11554.2003; PMID: 14557640
  • ZunigaA, LinigerM, MorinTN, MartyRR, WiegandM, IlterO, WeibelS, BilleterMA, KnuchelMC, NaimHY. Sequence and immunogenicity of a clinically approved novel measles virus vaccine vector. Hum Vaccin Immunother2013; 9:607 - 1; http://dx.doi.org/10.4161/hv.23242; PMID: 23324616
  • LorinC, MolletL, DelebecqueF, CombredetC, HurtrelB, CharneauP, BrahicM, TangyF. A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV. J Virol2004; 78:146 - 57; http://dx.doi.org/10.1128/JVI.78.1.146-157.2004; PMID: 14671096
  • LinigerM, ZunigaA, TaminA, Azzouz-MorinTN, KnuchelM, MartyRR, WiegandM, WeibelS, KelvinD, RotaPA, et al. Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses. Vaccine2008; 26:2164 - 74; PMID: 18346823
  • CantarellaG, LinigerM, ZunigaA, SchillerJ-T, BilleterM, NaimHY, GlueckR. Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma. Vaccine2009; 27:3385 - 90; http://dx.doi.org/10.1016/j.vaccine.2009.01.061; PMID: 19200837
  • DesprèsP, CombredetC, FrenkielMP, LorinC, BrahicM, TangyF. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis. J Infect Dis2005; 191:207 - 14; http://dx.doi.org/10.1086/426824; PMID: 15609230
  • BrandlerS, TangyF. Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines. Comp Immunol Microbiol Infect Dis2008; 31:271 - 91; http://dx.doi.org/10.1016/j.cimid.2007.07.012; PMID: 17869338
  • KnuchelM, MartyRR, Azzouz MorinTN, IlterO, ZunigaA, NaimHY. Relevance of pre-existing immunity against recombinant measles vector. Hum Vaccin Immunother2013; 9:599 - 606; http://dx.doi.org/10.4161/hv.23241; PMID: 23324399
  • SpielhoferP, BächiT, FehrT, ChristiansenG, CattaneoR, KaelinK, BilleterMA, NaimHY. Chimeric measles viruses with a foreign envelope. J Virol1998; 72:2150 - 9; PMID: 9499071
  • FehrT, NaimHY, BachmannMF, OchsenbeinAF, SpielhoferP, BucherE, HengartnerH, BilleterMA, ZinkernagelRM. T-cell independent IgM and enduring protective IgG antibodies induced by chimeric measles viruses. Nat Med1998; 4:945 - 8; http://dx.doi.org/10.1038/nm0898-945; PMID: 9701248
  • RussellSJ, PengKW. Measles virus for cancer therapy. Curr Top Microbiol Immunol2009; 330:213 - 41; http://dx.doi.org/10.1007/978-3-540-70617-5_11; PMID: 19203112
  • KünziV, OberholzerPA, HeinzerlingL, DummerR, NaimHY. Recombinant measles virus induces cytolysis of cutaneous T-cell lymphoma in vitro and in vivo. J Invest Dermatol2006; 126:2525 - 32; http://dx.doi.org/10.1038/sj.jid.5700529; PMID: 16960554
  • HeinzerlingL, KünziV, OberholzerPA, KündigT, NaimH, DummerR. Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells. Blood2005; 106:2287 - 94; http://dx.doi.org/10.1182/blood-2004-11-4558; PMID: 15961518
  • RussellSJ, PengKW, BellJC. Oncolytic virotherapy. Nat Biotechnol2012; 30:658 - 70; http://dx.doi.org/10.1038/nbt.2287; PMID: 22781695
  • ElsedawyNB, RussellSJ. Oncolytic vaccines. Expert Rev Vaccines2013; 12:1155 - 72; http://dx.doi.org/10.1586/14760584.2013.836912; PMID: 24124877
  • RussellSJ, FederspielMJ, PengKW, TongC, DingliD, MoriceWG, LoweV, O’ConnorMK, KyleRA, LeungN, et al. Remission of disseminated cancer after systemic oncolytic virotherapy. Mayo Clin Proc2014; 89:926 - 33; http://dx.doi.org/10.1016/j.mayocp.2014.04.003; PMID: 24835528
  • MsaouelP, OpyrchalM, Domingo MusibayE, GalanisE. Oncolytic measles virus strains as novel anticancer agents. Expert Opin Biol Ther2013; 13:483 - 502; http://dx.doi.org/10.1517/14712598.2013.749851; PMID: 23289598
  • GalanisE. Therapeutic potential of oncolytic measles virus: promises and challenges. Clin Pharmacol Ther2010; 88:620 - 5; http://dx.doi.org/10.1038/clpt.2010.211; PMID: 20881957

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.